Skip to main content
Premium Trial:

Request an Annual Quote

Christopher McLeod Becomes CEO of 454 Life Sciences, Jonathan Rothberg Steps Down as CuraGen CEO, David Schwartz Starts as Director of NIEHS and NTP, Alec Jeffreys Joins Inventors Hall of Fame, and Others

Kirk Malloy has been promoted to vice president of customer solutions at Illumina, the company said last week. He joined the company in 2002 as senior director of customer solutions. Previously, he held positions at Biosite and Qiagen. Malloy received PhD and MS degrees in marine biology and biochemistry from the Universityof Delaware and a BS in biology from the Universityof Miami.

Jonathan Rothberghas stepped down as chief executive officer of CuraGen, the company said last week. Rothberg, who announced his intention to resign as CEO in April, will remain on the CuraGen board of directors and be chairman of the board of 454 Life Sciences, a CuraGen subsidiary. Rothberg is replaced as CEO on an interim basis by Patrick Zenner, a CuraGen board member and former president and CEO of Hoffmann-La Roche.


Christopher McLeod has been named president and CEO of 454 Life Sciences. He used to be CuraGen's executive vice president.

John Gordon has become vice president of worldwide human resources of Millipore, the company said last week. Prior to joining Millipore, he was a consultant, and before that, corporate vice president of human resources for Sentara. Gordon holds an MBA from ColumbiaUniversityand a BSc from the London School of Economics.

John Lewis has become vice president of worldwide sales for Eklin Medical Systems, the Sunnyvale, Calif.-based digital radiography company said yesterday. He has held senior sales positions at Beckman Instruments, Molecular Dynamics, Alara and Celera Genomics. Lewis holds a BSc from the Universityof Floridain zoology.

David Schwartz will start his appointment as new director of the National Institute of  Environmental Health Sciences  and the National Toxicology Program on May 23, NIH said yesterday. He was named director of these institutes last fall. Schwartz comes to NIH from DukeUniversity, where he is director of the pulmonary, allergy, and critical care division and vice chair of research in the department of medicine. He holds an MD from the University of California San Diego, an MPh from Harvard School of Public Health, and a BA in biology from the Universityof Rochester.

Court Turner has been promoted to vice president of strategic alliances and senior legal counsel, Stewart Noble to vice president of discovery, and Andy Shiau to director of biology of Kalypsys, the San Diego-based company said on Monday. Turner, who joined Kalypsys in 2002 as director of legal affairs, holds a law degree from the University of San Diego and a degree in psychology from San DiegoStateUniversity. Noble, who came to Kalypsys in 2003 as director of chemistry, holds PhD and bachelor's degrees in chemistry from the Universityof Birmingham in England. Shiau, a group leader at Kalypsys since last year, holds a PhD in chemistry from the University of California at San Francisco and a bachelor's degree in molecular and cell biology from the Universityof Californiaat Berkeley.

The Ontario Genomics Institute has named five new directors to its board: John Molloy, president and chief executive officer of Parteq Innovations; Mark Poznansky, president and scientific director of the Robarts Research Institute; Cheryl Reicin, practice leader of the technology and life sciences group at Torys; Niclas Stiernholm, chief executive officer of Trillium Therapeutics; and Brian Underdown, managing director of technology investing at MDS Capital.


Molloy holds an MBA from Queen's University, Poznansky received a PhD in physiology from McGill University, Reicin has a JD from Harvard Law School and a BA from Columbia University, Stiernholm holds a PhD in immunology from the University of Toronto, and Underdown has a PhD in immunology from Washington University in St. Louis.

Alec Jeffreys was inducted to the National Inventors Hall of Fame last week for inventing genetic fingerprinting, the organization said last week. He is a researcher at the Universityof Leicester in the UKand holds a degree from the Universityof Oxford.

Inventors may be nominated by anyone for induction into the Hall of Fame, but they must hold a U.S.patent to be considered. The nominee's invention must have contributed to the welfare of society and have promoted the progress of science and the useful arts, according to the organization.

Mario Capecchi and Oliver Smithies have jointly won  the 2005 March of Dimes Prize in Developmental Biology for developing the gene targeting technology, the March of Dimes Birth Defects Foundation said last week. Capecchi is a professor at the department of human genetics at the University of Utah School of Medicine. Smithies is a professor of pathology and laboratory medicine at the University of North Carolina Chapel Hill. The two researchers received the award, which comes with $250,000 in cash, at a ceremony last week.

Promoted? Changing jobs?GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.